Translation initiation is important for the regulation of both cell growth and cell division. It is uniquely poised to coordinate overall cell proliferation by its effects on both growth and division. A number of translation initiation factors are transcriptional targets of c-myc in a variety of assays. In particular, the mRNA cap-binding protein eIF4E has a myc-binding sequence in its promoter that is myc responsive in reporter assays and contains a highaffinity myc-binding site in chromosome immunoprecipitation experiments. Several differential expression screens have demonstrated altered levels of eIF4E, along with several other translation initiation factors, in response to alterations of c-myc levels. The potential for eIF4E and other translational control elements to mediate myc's transforming functions is particularly important because eIF4E is itself a known oncogenic factor. The ability of translation initiation factors to affect both cell division control and cell growth control coincides with myc's remarkable effects on both cell growth and cell division.
Translation initiation is important for the regulation of both cell growth and cell division. It is uniquely poised to coordinate overall cell proliferation by its effects on both growth and division. A number of translation initiation factors are transcriptional targets of c-myc in a variety of assays. In particular, the mRNA cap-binding protein eIF4E has a myc-binding sequence in its promoter that is myc responsive in reporter assays and contains a highaffinity myc-binding site in chromosome immunoprecipitation experiments. Several differential expression screens have demonstrated altered levels of eIF4E, along with several other translation initiation factors, in response to alterations of c-myc levels. The potential for eIF4E and other translational control elements to mediate myc's transforming functions is particularly important because eIF4E is itself a known oncogenic factor. The ability of translation initiation factors to affect both cell division control and cell growth control coincides with myc's remarkable effects on both cell growth and cell division. Oncogene (2004 Oncogene ( ) 23, 3217-3221. doi:10.1038 Keywords: translational; control; eIF4E; ribosomal synthesis; rDNA transcription Malignant cells develop as the result of an accumulation of a finite set of genetic mutations that deregulate normal cellular proliferation. Disruption of intracellular pathways by as few as three genetic manipulations seems to define a lower limit of perturbations required for a malignancy to develop (Hahn et al., 1999) . Recent metasummaries hint that a minimum of six processes must be altered in every cancer cell before they become malignant. Those changes include development of resistance to growth inhibition, evasion of apoptosis, immortalization, development of mitogenic independence, acquisition of autologous angiogenic regulation, and development of intrinsic invasive properties (Hanahan and Weinberg, 2000; ). Yet, these literature summaries have often neglected a more basic property of all cancerous cells, the ability to add cellular mass without being limited by the normal growth mechanisms of the cell. Since cell division is completely dependent on the ability to grow to a minimum size threshold, this property is fundamental to both normal and malignant growth (Baserga, 1985) . When the minimally perturbing set of genes used to fully transform human cells was more carefully analysed, it became apparent that resistance to nutrient deprivation was an equal partner to all of the other genetic changes required in malignant cells . Despite the simplicity of the logic that cells must grow in order to proliferate, relatively less attention has been given to studies of the genetic mechanisms by which cell growth is perturbed compared to other aspects of cellular proliferation. Interestingly, examination of the c-myc oncogene led the way into these studies, just as c-myc has been a paradigm for so many aspects of tumor biology. In reviewing c-myc's functions, it is always important to remember that its deregulation in Burkitt's lymphomas results in the most rapidly proliferating known human tumor (Iversen et al., 1974) . Thus, it is no surprise to find that myc can deregulate many aspects of cell growth.
The broad consensus of work on c-myc places it squarely in a group of oncogenes that regulate transcription (Amati et al., 2001) . Overwhelming evidence has shown that c-myc both positively and negatively regulates distinct sets of genes. Furthermore, its interactions with protein components of the chromatin remodeling complexes and with histone-acetyl transferases firmly establish that role. On the other hand, the relative weakness of c-myc in standard transactivation assays remains a conundrum in the face of its potent oncogenic effects (Kretzner et al., 1992a) . Moreover, the known binding sequence for c-myc, CACGTG, occurs frequently in the genome and the list of experimentally confirmed myc-regulated genes is startling in its breadth . In general, c-myc appears to be a relatively weak transactivator of a broad array of genes that are rate-limiting steps in nearly all aspects of normal cellular proliferation. In this context, its effects on growth regulation are to be expected.
Rigorous definitions of cell growth remain elusive. The earliest definitions of cell growth centered on cell size, cell mass, net protein content, and ribosomal rRNA (Killander and Zetterberg, 1965; Baserga, 1985) . Myc-regulated genes now include those involved in so many aspects of cell growth that it seems best to use the loosest possible definition of growth to understand just how important myc is to the whole physiology of the growing cell. If there is a part of the cell that needs to increase from one cell to the next, myc seems to regulate a rate-limiting step in its metabolism.
The first hint that myc can regulate cell growth came from myc-ER cells that express conditionally active c-myc that require the addition of estradiol for myc to function (Eilers et al., 1989) . The initial description of those cells demonstrated myc's ability to directly induce entry into S phase. However, additional experiments revealed that net protein synthesis markedly increased 8 h after the activation of the conditional allele of myc, many hours before DNA synthesis increased. Indeed, DNA synthesis did not occur until myc had been active for nearly 24 h (Rosenwald et al., 1993b; Rosenwald, 1996; Schmidt, 1999) . This finding has provided the background for many subsequent experiments confirming a role for myc in cell growth.
Just as cell growth is an elusive concept, the idea of net protein synthesis is also elusive. The rate at which a radioactive amino-acid precursor will be incorporated into all of the proteins being synthesized at any given time point is the sum of multiple components of translation, balanced by ongoing degradation, summed over all the proteins of the cell. Components of the translational apparatus that will affect these sums include the number of ribosomes, the rate at which ribosomes are recruited to the mRNA to initiate translation, the rate at which the ribosomes elongate the nascent peptide, the rate at which ribosomes are terminated in order to recycle, and the rate at which misfolded proteins might be immediately degraded (Matthews et al., 2000) . All of these steps can be rate limiting for synthesis of individual proteins since examples of translational control can be found for all of these steps. However, in aggregate, the cell apparently regulates translation primarily at its initial step, the rate of initiation of ribosomal recruitment to the 5 0 end of mRNAs. Evidence for translation initiation as a key regulatory step in protein synthesis has centered on the fact that most actively translating mRNAs have a maximum number of ribosomes loaded while undergoing translation, as if elongation components were present in excess (Matthews et al., 2000) . The cellular content of translation initiation factors further supports this view since translation initiation factors are the least abundant components of the translational apparatus (Duncan and Hershey, 1983; Duncan and Hershey, 1985) .
Translation initiation factor eIF4E binds the 7-methyl guanosine cap structure at the 5 0 end of all mRNAs as the initial step in translation. It is a particularly interesting component of the translational apparatus because overexpression of eIF4E transforms cells (Lazaris-Karatzas et al., 1990) . In evaluating the potential for transcriptional regulation of eIF4E, parallel regulation of eIF4E mRNA and myc levels became apparent (Rosenwald et al., 1993b) . Levels of eIF2a, the methionyl tRNA recruitment factor, similarly paralleled myc levels, although with poorer fidelity. These parallels fit with the longtime view that increased cell growth precedes, and is required for, DNA synthesis to occur in dividing cells (Killander and Zetterberg, 1965; Hartwell and Unger, 1977; Johnston et al., 1977) . Nuclear run-off assays in the conditional mycer cells demonstrated that myc could activate transcription of eIF4E. Cloning of the eIF4E promoter provided the strong supportive evidence that it contains two canonical CACGTG motifs known to be the c-myc-binding site (Blackwell et al., 1990; Jones et al., 1996) . One problematic feature of c-myc is its relatively weak activity in reporter gene assays (Kretzner et al., 1992b) . Importantly, myc could transactivate the eIF4E promoter in standard reporter assays but, more importantly, dominant negative forms of c-myc downregulated eIF4E promoter activity (Jones et al., 1996) . These formal connections between myc's transactivating activity and a gene involved in protein synthesis revealed an important connection between c-myc and growth control. A connection between myc and translation initiation makes particular sense because translation initiation elements have particular effects on translation of cell cycle regulators (Polymenis and Schmidt, 1997; Polymenis and Schmidt, 1999) . These ideas provided a biochemical outline for how cell growth might regulate cell division.
Identification of the Drosophila homologue of human myc, dMyc, allowed formal testing of the role of c-myc in cell growth control (Gallant et al., 1996) . This formal testing showed that either loss or gain of dMyc had primary effects on cell size in developing embryos with only secondary effects on cell division rates (Johnston et al., 1999) . These findings were strongly supported by the development of somatic rat fibroblast cells lacking cmyc that also exhibited a primary growth defect (Mateyak et al., 1997) . Protein synthesis was markedly impaired in these cells and their cell division rate precisely paralleled the degree of the growth defect. This interesting cell line was then used to identify mRNA transcripts that required the continuous presence of c-myc for full expression (Bush et al., 1998) . Expression of a surprisingly small number of genes decreases in the total absence of c-myc, although one must consider that many of the genes proposed as candidate myc targets are themselves critical to all aspects of cell metabolism. This set of critical genes is likely to require multiple redundant transcriptional controls that might easily substitute for c-myc in its absence, yet be critical targets during the myc upregulation that occurs in cancer cells. In the opposite direction, upregulation of myc in transforming cells in transgenic mice has profound effects on cell size and protein synthesis (Iritani and Eisenman, 1999) . A plethora of myc targets have now been identified. On average one might expect that CACGTG will occur three times in each gene, so it is not surprising to find a long list of myc candidates. The most interesting element of this search has been the result that candidate myc targets largely function in normal cellular growth and metabolism (Figure 1 ).
The fascinating array of cell growth genes whose mRNAs can be altered by c-myc is confounded by some inconsistencies between the various screens that have identified those genes. The development of quantitative immunoprecipitation assays allowed a recent screen to identify promoters that are genuinely occupied in vivo by c-myc, which has helped to address these inconsistencies (Fernandez et al., 2003; Orian et al., 2003) . These CHIP assays were carried out in actively proliferating myeloblastic cells known to overexpress c-myc, as well as in Drosophila. The mammalian screen preselected for genes whose promoters contained CACGTG motifs. The translation initiation factors that contained highaffinity myc-binding sites included eIF4E, eIF4A, and eIF5A. Ribosomal protein promoters L13A, L19, L22, L27A, S19, and S6 also demonstrated high-affinity mycbinding sites. For the moment, this approach provides the most compelling evidence that myc is a direct transcriptional regulator of these proteins because myc is caught in the act, binding directly to the promoter.
The functional significance of myc's potential activation of translation initiation goes beyond its effects on cell growth. Complex translational control elements are present in a broad variety of mRNAs. These can often be identified as long 5 0 untranslated leader sequences containing high GC content (Kozak, 1991) . These elements usually act as translational repressors, slowing progress of the scanning ribosomal assembly to the ATG initiation codon. They are thought to be overrepresented in the least abundant mRNAs that are most critical to cell proliferation controls. Yeast mutants whose eIF3Z is temperature sensitive (cdc63) most effectively demonstrate the importance of these elements. When these mutants are switched to the restrictive temperature to limit translation initiation, they continue to grow in size but cease entering the S phase of the cell cycle (Hanic-Joyce et al., 1987) . Both mutational and functional studies identified the major G1 regulatory control cyclin, cln3, as the major translational target of the cdc63 mutation (Polymenis and Schmidt, 1997) . A parallel control may exist in mammalian cells because the cyclin D1 homologue of cln3 has been repeatedly shown to be translationally affected by factors regulating eIF4E (Rosenwald et al., 1993a; Rosenwald et al., 1995; Rousseau et al., 1996; Brewer et al., 1999; Hidalgo and Rowinsky, 2000; Nelsen et al., 2003) . This direct effect of translation initiation factors on mRNAs that regulate cell division may be especially important for mammalian myc's role in cell proliferation because myc's predominant role in normal mouse cell proliferation is to regulate cell division (Trumpp et al., 2001) . (1) Glucose metabolism is perturbed by antisense c-myc and myc increases glycolysis (Valera et al., 1995; Shim et al., 1997; Shim et al., 1998; Lewis et al., 2000; Osthus et al., 2000; Collier et al., 2003) . (2) Mitochondrial homeostasis is influenced by mycer and in myc-null cells (Wonsey et al., 2002; Haggerty et al., 2003) . (3) Ribosomal content and ribosomal genes are increased by c-myc (as well as N-myc), and RNA polymerase III transcription is activated by c-myc (Coller et al., 2000; Greasley et al., 2000; Kim et al., 2000; Boon et al., 2001; Zeller et al., 2001; Watson et al., 2002; Gomez-Roman et al., 2003) . (4) Amino-acid metabolism carbon sources are altered in myc-null cells (Nikiforov et al., 2002) . (5) Translation initiation factors have been upregulated targets in several screens (Bello-Fernandez et al., 1993; Rosenwald et al., 1993b; Coller et al., 2000; Kim et al., 2000) . Ornithine decarboxylase is involved in both translation initiation through its role in generating the hypusine required for eIF5A function, and in polyamine synthesis and is one of the more convincing myc-targets in multiple screens (Bello-Fernandez et al., 1993; Pena et al., 1993; Wagner et al., 1993; Packham and Cleveland, 1994; Tobias et al., 1995; Haggerty et al., 2003) . (6) Iron metabolism can be regulated by myc, although in this case myc works as a repressor (Wu et al., 1999) . Chromosome immunoprecipitation assays demonstrate that myc is present in vivo at the promoters of eIF4E, eIF5A, and the glucose transporter (highlighted in bold, red italics) (Fernandez et al., 2003) We recently developed a constitutively active inhibitor of translation initiation to better examine its global role in cell proliferation (Lynch et al., 2004) . The 4E-binding protein (4EBP) inhibitor of eIF4E antagonizes its functions and is highly regulated by signal transduction pathways that phosphorylate and inactivate the 4EBP (Lin et al., 1994) . By mutating all of these inactivation sites in the 4EBP, we developed a constitutive inhibitor of eIF4E function. Importantly, constitutive expression of this eIF4E inhibitor blocked transformation by cmyc, underlining the potential importance of eIF4E as a myc regulatory target in cancer. Moreover, the main effects of the constitutively active 4EBP turned out to be on cell division rather than cell growth. This study provides a physiological confirmation that myc transcriptional effects on translation initiation are important to the overall control of cell proliferation.
A number of features of myc's role in regulating translation initiation remain puzzling at this point. First, why does loss of c-myc seemingly fail to lower expression of translation initiation factors? Are there compensating transcriptional elements that support eIF4E and eIF5A levels in myc's absence? Second, what are the translational target's of myc's effects? It is particularly intriguing to note that ornithine decarboxylase is a prominent transcriptional target of c-myc and a translational target of eIF4E (Bello-Fernandez et al., 1993; Pyronnet et al., 1996; Rousseau et al., 1996) . This suggests that control of translation initiation by c-myc could amplify its transcriptional effects on particular proteins. The current state of knowledge about myc's effects on translation initiation would certainly encourage further studies in this area.
